4baseCare Secures Latest Funding Round

4baseCare secured an undisclosed amount in its latest Series B, adding another data point to the Legal, Regulatory & Compliance funding market.

4baseCare Raises an undisclosed amount in Funding

4baseCare announces close of Series B round at Rs 128 Cr. The deal aims to take its cancer testing platform global - IndiaMedToday. Published: Thu, 11 Jun 2026 06:39:39 GMT Infosys-backed 4baseCare raises ₹128 crore, plans to take its cancer testing platform global - IndiaMedToday.

Investors Behind the Funding

The round was backed by undisclosed investors. Funding Intelligence tracks this investor activity alongside sector momentum, co-investor patterns, and recent comparable raises.

Company Profile and Market Context

4baseCare operates in Legal, Regulatory & Compliance. 4baseCare's Series B round shows investors are still backing legaltech platforms with real scale narratives. At fresh capital, the deal suggests buyers want category leaders that can turn AI, automation, or workflow leverage into durable enterprise demand.

Strategic Use of Funds

Published: Thu, 11 Jun 2026 06:39:39 GMT Infosys-backed 4baseCare raises ₹128 crore, plans to take its cancer testing platform global - IndiaMedToday. The transaction supports efforts to take its cancer testing platform global - IndiaMedToday.

Looking Ahead

4baseCare announces close of Series B round at Rs 128 Cr

Source reference: original announcement/article.